Absorption of erythromycin. A cross-over study in healthy volunteers
- PMID: 1106445
Absorption of erythromycin. A cross-over study in healthy volunteers
Abstract
The absorptions of 6 erythromycin preparations were compared in a cross-over study in healthy humans. In a single-dose study, 500 mg of each preparation was, after an overnight fast, given to 10 volunteers. The two enterosoluble preparations of erythromycin base studied were absorbed slowly, and the peak serum concentration (1.5-2 mg/l) was achieved only at 4 h. The absorption of the stearates was quick, but especially one of them was poorly absorbed, the serum concentration being always below 1 mg/l. Both of the two estolates gave highest apparent concentrations, and the maximum serum level (2-2.5 mg/l) was achieved at 2 h, but the concentration of active erythromycin remains unknown. In the second part of the study, two erythromycin stearates and one base preparation were given at 6-h interval in a cross-over fashion, each for 4 days. On the 4th day, blood samples were analyzed. The erythromycin base gave higher serum concentrations than did the two stearates, which were equivalent. It seems doubtful that the erythromycin stearate at the dose of 250 mg every 6th hour would give satisfactory serum levels of erythromycin which would be effective against most bacteria during the whole treatment.
Similar articles
-
Bioavailability and effect of food on the gastrointestinal absorption of two erythromycin derivatives.Ann Clin Res. 1978 Oct;10(5):258-62. Ann Clin Res. 1978. PMID: 367255 Clinical Trial.
-
Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.J Pharm Sci. 1979 Feb;68(2):150-5. doi: 10.1002/jps.2600680208. J Pharm Sci. 1979. PMID: 423080
-
Effect of food on absorption and hydrolysis of erythromycin acistrate.Arzneimittelforschung. 1992 Jan;42(1):73-6. Arzneimittelforschung. 1992. PMID: 1586385 Clinical Trial.
-
5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.Dan Med Bull. 2000 Feb;47(1):20-41. Dan Med Bull. 2000. PMID: 10709142 Review.
-
Selection of an oral erythromycin product.Am J Hosp Pharm. 1980 Sep;37(9):1199-205. Am J Hosp Pharm. 1980. PMID: 6998290 Review.
Cited by
-
[Tissue penetration of erythromycin (author's transl)].Infection. 1979;7(3):129-45. doi: 10.1007/BF01641314. Infection. 1979. PMID: 478653 German.
-
Single-dose fasting bioequivalence assessment of erythromycin stearate tablets in man.J Pharmacokinet Biopharm. 1979 Aug;7(4):355-68. doi: 10.1007/BF01062534. J Pharmacokinet Biopharm. 1979. PMID: 512842
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources